TomoTherapy technology is developed and manufactured by TomoTherapy Inc. and is exclusively distributed in Mexico and Central America by Medicina y Tecnologia S.A. de C.V. (Medytec), a Mexico-based provider of advanced medical technology.
To celebrate the milestone of being the first group to bring advanced TomoTherapy treatments to Central and South America, the International Cancer Center will host an opening ceremony today. More than 500 guests are expected to attend.
Ad Statistics
Times Displayed: 50697
Times Visited: 1465 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About the International Cancer Center of El Salvador
The Diagnostic Hospital's International Cancer Center of El Salvador is the first institution in Central and South America to offer radiation therapy using the advanced TomoTherapy® platform. It is also the only institution in El Salvador that offers a comprehensive range of treatment modalities, including: surgery; radiosurgery; nutritional support; emotional support; pain management; rehabilitation; and reconstructive surgery. The team at the International Cancer Center uses a holistic, multidisciplinary approach to treating the disease, including physical, psychological, emotional support, and a focus on education and prevention.
For more information please visit: www.centrodecancer.com.sv
About Medicina y Tecnologia S.A. de C.V. (Medytec)
Medicina y Tecnologia S.A. de C.V. (Medytec) is a distributor and supplier of high technology medical equipment, including services and clinical training, for radiation oncology manufacturers. Medytec has introduced leading edge technology to a number of centers throughout Latin America. Find more information at Medytecmex.com.
About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
Back to HCB News
